Clinical Trials
28 trialsTRIDENT-1
Turning Point Therapeutics, Inc.
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
M.D. Anderson Cancer Center
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Jazz Pharmaceuticals
ARROW
Hoffmann-La Roche
Re-MATCH
University of Florida
A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
BeiGene
Vorasidenib Expanded Access Program
Servier
Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's Sarcoma
Gradalis, Inc.
5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade Gliomas
Sociedad de Lucha Contra el Cáncer del Ecuador
OPTIMUM
Jubilant DraxImage Inc.
Establishment and Clinical Application of Risk Classification Model Based on Molecular Typing of Medulloblastoma in Children
Beijing Tiantan Hospital
SEPTRALU
Sociedad Española de Medicina Nuclear e Imagen Molecular
CAPTIVE
DNAtrix, Inc.
Trial of Afatinib in Pediatric Tumours
Boehringer Ingelheim
Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases
National Institutes of Health Clinical Center (CC)
Clinical Study of an Dendritic and Glioma Cells Fusion Vaccine With IL-12 for Treatment-naïve GBM Patients.
Second Affiliated Hospital, School of Medicine, Zhejiang University
NOA-07
University of Regensburg
Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors
Washington University School of Medicine
TARGET-I
DNAtrix, Inc.
Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
Masonic Cancer Center, University of Minnesota
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
NET
Assistance Publique - Hôpitaux de Paris
Cixutumumab in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)
Merck Sharp & Dohme LLC
Combined O-(2-[18F]Fluoroethyl)-L-tyrosine (FET) Positron Emission Tomography (PET) and Simultaneous Magnetic Resonance Imaging (MRI) Follow-up in Re-irradiated Recurrent Glioblastoma Patients
Ludwig-Maximilians - University of Munich
Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases
M.D. Anderson Cancer Center
Establishment of a Brain and Spinal Tumor Tissue Bank
Taipei Medical University WanFang Hospital
A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors
National Institutes of Health Clinical Center (CC)